title: Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma: is it safe?
authors.forename: Güngör
authors.initials: G
authors.lastname: Utkan
authors.forename: Bülent
authors.initials: B
authors.lastname: Yalçin
authors.forename: Abdullah
authors.initials: A
authors.lastname: Büyükçelik
authors.forename: Samet
authors.initials: S
authors.lastname: Yalçin
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D008654:Mesothelioma / Q000188:drug therapy* / Q000601:surgery; D009017:Morbidity; D010997:Pleural Neoplasms / Q000188:drug therapy* / Q000601:surgery; D011013:Pneumonectomy; D013923:Thromboembolism / Q000139:chemically induced; D000093542:Gemcitabine
chemical_list: D003841:Deoxycytidine; D002945:Cisplatin; D000093542:Gemcitabine